The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. (Q39003096)
Jump to navigation
Jump to search
scientific article published on 18 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. |
scientific article published on 18 April 2014 |
Statements
The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells (English)
Kaamar Azijli
Ingrid A M van Roosmalen
Jorn Smit
Saravanan Pillai
Masakazu Fukushima
Steven de Jong
Godefridus J Peters
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference